5777 W. Century Blvd. Suite 360

Los Angeles, CA 90045

310-258-5000

COMPUMED ANNOUNCES BOARD ADDITION

LOS ANGELES, CA (December 19, 2014) - CompuMed, Inc. (OTCPink: CMPD), the leaders in providing Enterprise

Telemedicine Solutions, today announced the appointment of Benjamin Large to its Board of Directors.

"On behalf of the CompuMed Board of Directors, I would like to welcome Ben to the company. We are very pleased to have someone of his caliber join our board," said W. Scott Rombach, CompuMed's CEO and President.

About Benjamin Large

Benjamin Large in an investment manager. Mr. Large was previously a Senior System Engineer on satellite programs where

he was responsible for the design and analysis of the satellite communications systems. Mr. Large worked on early stage advanced technology proposals that lead to cutting edge new product designs. He was a lead software developer of analytical modeling tools that were used for early stage risk reduction and lowered verification costs to allow for more competitive bidding. Mr. Large has a M.S. in Electrical Engineering from the University of Southern California and a B.S. in Computer Engineering from Purdue University.

About CompuMed, Inc.

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced

costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com.

Forward-Looking Statements

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are
forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of a ppropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
CompuMed, Inc. Investor Relations: investorrelations@compumedinc.com(310) 258-5000 x117

distributed by